Physician profile
Nolan P Machernis
NPI 1669765681
$3,361.52
in general payments reported to CMS, 2019-2025
21 companies · $1,167 in 2025
The $1,167 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $804 · 2020: $157 · 2021: $525 · 2023: $425 · 2024: $283 · 2025: $1,167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,874.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $913.06 | 2019-2025 | Opticross, Rotablator Rotational Atherectomy System Console Kit, Opticross 6 |
| Abbott Laboratories | $646.52 | 2019-2025 | Jot Dx, Dragonfly Opstar, Pressurewire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $394.38 | 2024-2025 | Lifevest |
| Medtronic Vascular, INC. | $308.42 | 2019 | |
| Medtronic, INC. | $142.74 | 2023-2024 | Valiant Captivia, Onyx Frontier |
| Medical Device Business Services, INC. | $141.46 | 2019 | |
| Edwards Lifesciences Corporation | $119.52 | 2025 | |
| Shockwave Medical, INC | $111.29 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $78.21 | 2024-2025 | Repatha, Repatha |
| Alnylam Pharmaceuticals INC. | $71.99 | 2025 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $67.51 | 2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $63.45 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $61.08 | 2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.11 | 2024-2025 | Jardiance |
| Abiomed | $41.68 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $39.61 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Scpharmaceuticals INC. | $34.22 | 2025 | |
| Pfizer INC. | $19.84 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.97 | 2025 | |
| Glaxosmithkline, LLC. | $16.37 | 2025 | Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $14.09 | 2025 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nolan Machernis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.